Trial of amifostine in autologous stem cell transplant
- PMID: 16273114
- DOI: 10.1038/sj.bmt.1705204
Trial of amifostine in autologous stem cell transplant
Comment on
-
Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation.Bone Marrow Transplant. 2005 May;35(10):971-7. doi: 10.1038/sj.bmt.1704946. Bone Marrow Transplant. 2005. PMID: 15778725 Clinical Trial.
Similar articles
-
[Bacteremia due to Capnocytophaga spp.: two cases].Enferm Infecc Microbiol Clin. 2003 Mar;21(3):168-9. Enferm Infecc Microbiol Clin. 2003. PMID: 12586027 Spanish. No abstract available.
-
High-dose CEB vs BEAM with autologous stem cell transplant in lymphoma.Bone Marrow Transplant. 2004 Oct;34(7):581-7. doi: 10.1038/sj.bmt.1704637. Bone Marrow Transplant. 2004. PMID: 15273714
-
Efficacy of diverse high-dose regimens followed by autologous peripheral blood stem cell transplantation in consecutive multiple myeloma patients: a single-centre analysis over a 12-year period.Ann Hematol. 2006 Mar;85(3):191-3. doi: 10.1007/s00277-005-0040-x. Epub 2005 Dec 20. Ann Hematol. 2006. PMID: 16365747 No abstract available.
-
[Stem cell therapy in multiple sclerosis: a clinical update].Z Rheumatol. 2009 May;68(3):214-5, 217-9. doi: 10.1007/s00393-008-0392-4. Z Rheumatol. 2009. PMID: 19399509 Review. German.
-
Frequency, severity and risk factors for oral mucositis after BEAM conditioning and autologous peripheral blood stem cell transplantation: a single center analysis and review of the literature.Leuk Lymphoma. 2007 Nov;48(11):2255-60. doi: 10.1080/10428190701636492. Leuk Lymphoma. 2007. PMID: 17990184 Review. No abstract available.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical